How much does Infigratinib cost? How much does it cost?

Infigratinib is an oral, targeted drug used to treat a rare type of cancer called cholangiocarcinoma. Cholangiocarcinoma is a malignant tumor that originates from bile ducts, or biliary epithelial cells, and can affect different parts of the biliary system, including intrahepatic bile ducts, extrahepatic bile ducts, and the gallbladder. Cholangiocarcinoma is often difficult to diagnose early and is often difficult to treat when it is diagnosed at an advanced stage.

Infigratinib/Infigratinib It is not currently available in the country, and it is unlikely to be included in medical insurance. Patients cannot purchase it domestically and can only purchase it through overseas channels. Foreign Infigratinib/Infigratinib only has original drugs, only American original drugs, and the price is as high as about 200,000.

Infitinib/Infigratinib's mechanism of action involves inhibiting a protein called fibroblast growth factor receptor (Fibroblast Growth Factor Receptor, FGFR), which is abnormally active in some patients with cholangiocarcinoma. By inhibiting FGFR, infigratinib can slow or stop the growth and spread of cancer cells.

Before usingInfigratinib/InfigratinibPatients need to tell their doctor about all of their medications and medical conditions, as some conditions may affect the safety and effectiveness of the treatment. In addition, Infigratinib/Infigratinib may be unsafe for pregnant and breastfeeding women, so appropriate contraception should be used during treatment.

Infigratinib/InfigratinibRepresents a new hope in the treatment of cholangiocarcinoma, especially for those patients with specific genetic alterations. However, the specific effects of treatment will vary depending on the individual patient's condition, so treatment must be individualized to each patient's needs. Patients need to work closely with their doctor during treatment, with regular monitoring and follow-up visits to ensure optimal results.